Platelet membrane biomimetic nanomedicine induces dual glutathione consumption for enhancing cancer radioimmunotherapy
Radiotherapy (RT) is one of the most common treatments for cancer. However, intracellular glutathione (GSH) plays a key role in protecting cancer from radiation damage. Herein, we have developed a platelet membrane biomimetic nanomedicine (PMD) that induces double GSH consumption to enhance tumor ra...
Saved in:
Main Authors: | Xiaopeng Li, Yang Zhong, Pengyuan Qi, Daoming Zhu, Chenglong Sun, Nan Wei, Yang Zhang, Zhanggui Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-12-01
|
Series: | Journal of Pharmaceutical Analysis |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2095177924000030 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A Smart Nanomedicine Unleashes a Dual Assault of Glucose Starvation and Cuproptosis to Supercharge αPD‐L1 Therapy
by: Yiming Xu, et al.
Published: (2025-01-01) -
Characterization and Comparison of Mesoporous Silica Particles for Optimized Drug Delivery
by: Xinyue Huang, et al.
Published: (2014-01-01) -
Effects of glutathione on the physicochemical properties of high hydrostatically pressure gelatinized maize starch
by: Wei Zhang, et al.
Published: (2025-01-01) -
Recent advances in self-targeting natural product-based nanomedicines
by: Haifan Liu, et al.
Published: (2025-01-01) -
Tomorrow’s Medicine Today: Nanomedicine in the Fight against Covid-19
by: Steven Mufamadi, et al.
Published: (2020-06-01)